Company profile: Curia
1.1 - Company Overview
Company description
- Provider of contract research, development, and manufacturing services for pharmaceutical and biopharmaceutical customers, covering discovery biology, synthetic and medicinal chemistry, and small-scale and commercial manufacturing. Formerly AMRI, Curia delivers offerings from R&D through commercial manufacturing.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Curia
IPA
HQ: Canada
Website
- Description: Provider of bioplatform-based, AI-driven antibody discovery and development services leveraging systems biology and multi-omics modeling. Offerings include target analysis and immunization, antibody discovery and characterization (sequencing and custom assays), developability profiling, and optimization/engineering (humanization, affinity maturation, chimerization). Includes LENSai Integrated Intelligence Technology for drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IPA company profile →
Chemoxy
HQ: United Kingdom
Website
- Description: Provider of independent contract manufacturing services, supplying quality materials to countless industries. One of Europe’s largest independent contract manufacturers, with strong health and safety standards and operational structures supporting consistent quality.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chemoxy company profile →
PackGene
HQ: United States
Website
- Description: Provider of CRO/CDMO services for gene and cell therapy, specializing in AAV vectors, mRNA, plasmid DNA, and lentiviral solutions. Offerings include AAV vector design and construction; small- to large-scale AAV production up to GMP; π-Icosa serotype screening; Express Gene-to-AAV from synthesis to packaging; and on-demand gene editing mRNAs (e.g., Cas9). Supports discovery, preclinical, and trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PackGene company profile →
Abveris
HQ: United States
Website
- Description: Provider of antibody discovery solutions for reagent and therapeutic applications, offering DiversimAb hyperimmune mouse technology for diverse monoclonal antibodies; Beacon single B-cell screening; hybridoma discovery (production, purification, sequencing, recombinant production); antigen production and design; anti-idiotype antibody discovery; and fully human antibodies via humanized mice.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abveris company profile →
Synequanon
HQ: United Kingdom
Website
- Description: Provider of data-focused specialist biometrics CRO services in Europe, serving pharmaceutical, biotechnology and animal healthcare companies in the UK, Europe and worldwide as a preferred clinical development partner.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synequanon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Curia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Curia
2.2 - Growth funds investing in similar companies to Curia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Curia
4.2 - Public trading comparable groups for Curia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →